Subsets of Patients With NETs Show Better Response to Cabozantinib
Published: | Updated:
Lowell B. Anthony, MD, discusses the potential benefits of cabozantinib for patients for different types of patients with neuroendocrine tumors.
Lowell B. Anthony, MD
Articles by Lowell B. Anthony, MD
Latest Updated Articles
Subsets of Patients With NETs Show Better Response to CabozantinibPublished: October 7th 2025 | Updated: October 31st 2025